Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy (Q40696451)

22 September 2017

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy (English)

1 reference

22 September 2017

1 reference

6

Burkert Pieske

1 reference

22 September 2017

7

Carsten Tschöpe

1 reference

22 September 2017

1

Felicitas Escher

1 reference

22 September 2017

4

Wolfgang Poller

1 reference

22 September 2017

5

Dirk Westermann

1 reference

22 September 2017

2

Uwe Kühl

1 reference

22 September 2017

3

Dirk Lassner

1 reference

22 September 2017

Heinz-Peter Schultheiss

series ordinal

8

1 reference

PubMed ID

27312326

22 September 2017

language of work or name

1 reference

16 June 2016

1 reference

Clinical Research in Cardiology

22 September 2017

1 reference

22 September 2017

105

1 reference

22 September 2017

12

1 reference

22 September 2017

1011-1020

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-016-1011-z

22 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

The management of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Immunosuppressive therapy in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Analysis of endomyocardial biopsies in suspected myocarditis--diagnostic value of left versus right ventricular biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Pathogenesis of myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Autoimmunological features in inflammatory cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

The role of perforin and granzymes in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

CD4+ and CD8+ CD28(null) T Cells Are Cytotoxic to Autologous Muscle Cells in Patients With Polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Structural biology of the cell adhesion protein CD2: alternatively folded states and structure-function relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-016-1011-Z

Cell death, proliferation and repair in human myocarditis responding to immunosuppressive therapy.

21 January 2018

1 reference

12 December 2020

Pathophysiology of cardiac inflammation: molecular mechanisms

1 reference

12 December 2020

Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure

1 reference

12 December 2020

Perforin-mediated myocardial damage in acute myocarditis

1 reference

12 December 2020

Human parvovirus B19-associated myocarditis

1 reference

12 December 2020

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

12 December 2020

Advances in the understanding of myocarditis

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Soci

1 reference

12 December 2020

Myocarditis: the Dallas criteria

1 reference

12 December 2020

10.1007/S00392-016-1011-Z

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

27312326